Radient Pharmaceuticals Corp. (RPC) Inks 5-Year Agreement with Hong Kong Based Distributor
Through its subsidiary AMDL Diagnostics Inc., Radient Pharmaceuticals Corp. today announced it has entered into a full-service five-year exclusive distribution agreement with Hong Kong based Bio-Asia Diagnostics Co. Ltd. (Bio-Asia). This distribution agreement will enable Radient Pharmaceuticals to bring its Onko-Sure™ IVD cancer test into the Hong Kong healthcare market. According to the terms of the agreement, Bio-Asia will purchase at least 800 Onko-Sure® test kits. Bio-Asia will be responsible for providing marketing, sales, and distribution services to get Onko-Sure in major diagnostic centers, clinical reference labs, and hospitals in Hong Kong. Additionally, Bio-Asia will reach out to hospitals and…